Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 6399872

Exercise echocardiography.

R A Stein
View original source ↗Export metadata ↓

Abstract

Echocardiographic assessment of changes in wall motion and ventricular dimensions with exercise may be of significant value in the evaluation of the patient with coronary artery disease. Topics covered in this article include exercise physiology, dynamic M-mode echocardiography and its limitations, two-dimensional dynamic exercise echocardiography, and echocardiography during isometric exercise.

Explore related subjects

Coronary DiseaseEchocardiographyElectrocardiographyExercise TestHumansIsometric ContractionMyocardial ContractionPhysical ExertionJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

R A Stein. 1984. Exercise echocardiography.. https://pubmed.ncbi.nlm.nih.gov/6399872/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2002

Selection of coronary stents.

In clinical practice, the operator must decide which stent is most appropriate for the patient. This article focuses on the features of stent design that make a specific stent more or less suitable for a particular type of lesion or anatomy: the "average" coronary lesion, the lesion situated on a curve, the ostial lesion, the bifurcational lesion, the lesion located at the left main stem, the calcified lesion, the chronic total occlusion, the small vessel, the saphenous vein graft, acute or threatened vessel closure, and special situations such as coronary aneurysms and perforations.

Coronary Disease↗
PubMed2002

Current concepts in insulin resistance, type 2 diabetes mellitus, and the metabolic syndrome.

A clustering of risk factors, including elevated triglycerides, decreased high-density lipoprotein cholesterol, hyperinsulinemia, and hypertension often are observed in patients who are insulin resistant. Insulin resistance has been found to play a critical role in the development of cardiovascular disease, particularly in patients with type 2 diabetes. Patients with insulin resistance have an increase in small, dense low-density lipoprotein (LDL) cholesterol, which is more atherogenic than large, buoyant LDL cholesterol. In the context of insulin resistance, insulin has reduced effects on the phosphatidylinositol 3 kinase (PI3K) pathway, whereas mitogen-activated protein kinase activity is maintained. The result is an exaggeration of the mitogenic actions of insulin leading to vascular smooth muscle proliferation and elevated plasminogen activator inhibitor (PAI)-1. Notably, nitric oxide-mediated vasodilation also is impaired, further contributing to atherogenicity. In addition, hyperinsulinemia further contributes to cardiovascular risk by promoting thrombosis. Patients who are insulin resistant have decreased fibrinolysis, as indicated by increased levels of PAI-1. Studies have shown that enhancing insulin sensitivity with insulin sensitizers, such as thiazolidinediones, may improve insulin resistance and limit the development of adverse cardiovascular consequences.

Coronary Disease↗